Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control study

Léo Plaçais, Stéphane Dalle, O. Dereure, Sabiha Trabelsi, S. Dalac, Délphine Legoupil, Henri Montaudié, Jean‐Philippe Arnault, Julie De Quatrebarbes, Philippe Saïag, F. Brunet‐Possenti, Thierry Lesimple, E. Maubec, F. Aubin, F. Granel‐Brocard, Jean‐Jacques Grob, Pierre‐Emmanuel Stoebner, Clara Allayous, Bastien Oriano, Caroline Dutriaux, Laurent Mortier, Célèste Lebbé